Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028?
Basic
2
Ṁ112027
41%
chance
1D
1W
1M
ALL
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of prostate adenocarcinoma in the United States before January 1, 2028. This does not include emergency use authorization or other forms of limited authorization. Resolves NO otherwise.
This question is managed and resolved by Manifold.
Get
1,000and
3.00
1,0003.00Related questions
Related questions
Will FDA approve any mRNA vaccine against stomach adenocarcinoma before 2028?
31% chance
Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
43% chance
Will FDA approve any mRNA vaccine against colorectal adenocarcinoma before 2028?
30% chance
Will FDA approve any mRNA vaccine against pancreatic adenocarcinoma before 2028?
19% chance
Will FDA approve any mRNA vaccine against melanoma before 2028?
49% chance
Will FDA approve any mRNA vaccine against esophageal adenocarcinoma before 2028?
33% chance
Will FDA approve any mRNA vaccine against squamous cell carcinoma before 2028?
35% chance
Will FDA approve any mRNA vaccine against any type of breast cancer before 2028?
31% chance
Will FDA approve any mRNA vaccine against glioblastoma before 2028?
20% chance
Will FDA approve any mRNA vaccine against myeloid leukemia before 2028?
34% chance